Pre-incubation of corneal donor tissue with sCD83 improves graft survival via the induction of alternatively activated macrophages and tolerogenic dendritic cells

Immune responses reflect a complex interplay of cellular and extracellular components which define the microenvironment of a tissue. Therefore, factors that locally influence the microenvironment and re-establish tolerance might be beneficial to mitigate immune-mediated reactions, including the rejection of a transplant. In this study, we demonstrate that pre-incubation of donor tissue with the immune modulator soluble CD83 (sCD83) significantly improves graft survival using a high-risk corneal transplantation model. The induction of tolerogenic mechanisms in graft recipients was achieved by a significant upregulation of Tgfb, Foxp3, II27, and II10 in the transplant and an increase of regulatory dendritic cells (DCs), macrophages (M phi) and T cells (Tregs) in eye-draining lymph nodes. The presence of sCD83 during in vitro DC and M phi generation directed these cells toward a tolerogenic phenotype leading to reduced proliferation-stimulating activity in MLRs. Mechanistically, sCD83 induced a tolerogenic M phi and DC phenotype, which favors Treg induction and significantly increased transplant survival after adoptive cell transfer. Conclusively, pre-incubation of corneal grafts with sCD83 significantly prolongs graft survival by modulating recipient M phi and DCs toward tolerance and thereby establishing a tolerogenic microenvironment. This functional strategy of donor graft pre-treatment paves the way for new therapeutic options in the field of transplantation.

Automated summary

The use of the immune modulator soluble CD83 (sCD83) to pre-incubate donor tissue significantly improves graft survival in a high-risk corneal transplantation model by modulating recipient M phi and DCs towards tolerance and establishing a tolerogenic microenvironment. This functional strategy opens up new therapeutic options in transplantation.